Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F66N1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,591
Award facts
- Contract value 100% obligated
- $11,591.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,591.38 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price contract, issued on January 23, 2026, with a completion date of January 26, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare systems, with performance to occur at its corporate office location in Conshohocken.
This delivery order supports military healthcare supply requirements through AmerisourceBergen's comprehensive prime vendor contract with DLA valued at $999,999,999.00 through December 2026. The parent entity, Cencora, Inc. (operating as AmerisourceBergen), holds an even larger IDC with DLA through December 2031 for global pharmaceutical support. Repatha, a cholesterol-lowering biologic medication, addresses cardiovascular health needs within the Defense Health Agency's medical supply chain, demonstrating the contractor's role in delivering specialty pharmaceutical products to military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F66N1?
SPE2DR26F66N1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F66N1 worth?
The government has obligated $11,591 on SPE2DR26F66N1.
Is contract SPE2DR26F66N1 an order under another contract?
Yes. SPE2DR26F66N1 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F66N1 competed?
The extent of competition for SPE2DR26F66N1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award